Researcher
Emeline Van Craenenbroeck
- Research Expertise:My research is focused on the physiological effects of exercise training in heart failure and aims to discover new therapies by studying exercise-induced benefits. Apart from an international reputation for the expertise in multicenter trials, the group is strong in translational research on heart failure with combined in vitro and in vivo evaluation of endothelial dysfunction, epigenetics studies, and the effect of exercise/rehabilitation as main focus.
- Keywords:HEART FAILURE, EXERCISE, Medicine
- Disciplines:Cardiology
- Research techniques:- leading clinical trials - laboratoria techniques: flowcytometry, cell culture, protein analysis, RTqPCR, histology
- Users of research expertise:NA
Affiliations
- Cardiovascular diseases (CARDIOVASC) (Research group)
Member
From1 Jan 2019 → Today - Translational Pathophysiological Research (TPR) (Research group)
Member
From1 Apr 2012 → 31 Dec 2018 - Translational Pathophysiological Research (TPR) (Research group)
Member
From1 Nov 2010 → 31 Mar 2012 - Translational Pathophysiological Research (TPR) (Research group)
Member
From1 Oct 2006 → 31 Oct 2010
Projects
1 - 10 of 26
- Running away from doxorubicin-induced skeletal muscle toxicity: investigating the molecular mechanisms and protective effects of physical exercise.From1 Nov 2022 → TodayFunding: FWO fellowships
- Eccentric muscle training in cardiac rehabilitation: randomized controlled trial to evaluate effectiveness and feasibility in heart failure patients with reduced ejection fraction.From1 Jul 2022 → 31 Dec 2023Funding: BOF - projects
- Vevo LAZR-X Photoacoustic Imaging System;From1 Jun 2022 → TodayFunding: FWO Medium Size Research Infrastructure
- Microvascular dysfunction in adults with a congenital heart disease and the effect of exercise training (MICONEX).From1 Nov 2021 → TodayFunding: FWO fellowships
- Mechanistic insights in mitral valve prolapse and associated left ventricular remodelling: Barlow's Disease versus Fibroelastic Deficiency.From1 Oct 2021 → TodayFunding: BOF - doctoral mandates
- Discovering the role of titin (TTN) in anthracycline-induced cardiac dysfunction in breast cancer.From1 Mar 2021 → TodayFunding: Foundations, funds and other with scientific goal
- Discovering the role of titin (TTN) in anthracycline-induced cardiotoxicity in breast cancer.From1 Jan 2021 → TodayFunding: FWO research project (including WEAVE projects)
- Right ventricular (dys)function in congenital heart disease: role of microvascular dysfunction and effect of exercise training.From1 Nov 2020 → 31 Oct 2021Funding: BOF - doctoral mandates
- Mitral valve prolapse and associated cardiomyopathy: impact of mitral valve prolapse subtype and genetics.From1 Nov 2020 → 31 Oct 2021Funding: Fund Recuperation Fiscal Exemption
- Chemotherapy-induced myotoxicity requires healthy skeletal musclesFrom1 Oct 2020 → TodayFunding: BOF - doctoral mandates
Publications
1 - 10 of 150
- Exercise training and high-sensitivity cardiac troponin-I in patients with heart failure with reduced ejection fraction(2024)
Authors: Egil Riveland, Torstein Valborgland, Anastasia Ushakova, Oyvind Skadberg, Trine Karlsen, Torstein Hole, Asbjorn Stoylen, Havard Dalen, Vibeke Videm, Elias Koppen, et al.
Pages: 1 - 12 - Personalized remotely guided preventive exercise therapy for a healthy heart (PRIORITY)(2023)
Authors: Camille De Wilde, Youri Bekhuis, Tatiana Kuznetsova, Jomme Claes, Guido Claessen, Karin Coninx, Elise Decorte, Delphine De Smedt, Dominique Hansen, Matthias Lannoo, et al.
Pages: 1 - 12 - Coronary microvascular dysfunction in patients with congenital heart disease(2023)
Authors: Inne Vanreusel, Vincent Segers, Emeline Van Craenenbroeck, An Van Berendoncks
Pages: 1 - 15 - Early detection of heart failure through exercise testing(2023)
Authors: Andreas Gevaert, Stephanie De Schutter, Emeline Van Craenenbroeck
Pages: 1401 - 1403 - Elevated oxidative stress in patients with congenital heart disease and the effect of cyanosis(2023)
Authors: Inne Vanreusel, Jan Taeymans, Emeline Van Craenenbroeck, Vincent Segers, An Van Berendoncks, Jacob J. Briede, Wendy Hens
Pages: 470 - 486 - Sex-related differences in left ventricular assist device utilization and outcomes(2023)
Authors: Sumant P. Radhoe, Nina Jakus, Jesse F. Veenis, Philippe Timmermans, Anne-Catherine Pouleur, Pawel Rubis, Emeline Van Craenenbroeck, Edvinas Gaizauskas, Eduardo Barge-Caballero, Stefania Paolillo, et al.
Pages: 1054 - 1065 - A good operation is not enough, when it comes to frail patients(2023)
Authors: Nikolaos Bonaros, Emeline Van Craenenbroeck
Pages: 1 - 3 - Doxorubicin-induced cardiovascular toxicity(2023)
Authors: Matthias Bosman, Dustin Krüger, Charles Van Assche, Hanne Boen, Cédric Neutel, Kasper Favere, Constantijn Franssen, Wim Martinet, Lynn Roth, Guido De Meyer, et al.
Pages: 2579 - 2590 - Variable clinical expression of a Belgian TGFB3 founder variant suggests the presence of a genetic modifier(2023)
Authors: Melanie Perik, Emmanuela Govaerts, Steven Laga, Inge Goovaerts, Johan Saenen, Emeline Van Craenenbroeck, Josephina Meester, Ilse Luyckx, Inez Rodrigus, Aline Verstraeten, et al.
Pages: 1 - 7 - Clinical and functional characterisation of a recurrent KCNQ1 variant in the Belgian population(2023)
Authors: Ewa Sieliwonczyk, Maaike Alaerts, Eline Simons, Dirk Snyders, Aleksandra Nijak, Bert Vandendriessche, Dorien Schepers, Dogan Akdeniz, Emeline Van Craenenbroeck, Katleen Knaepen, et al.
Pages: 1 - 12